VNDA
Companies
NASDAQ
Vanda Pharmaceuticals Inc.
Health Care
$4.53
-$0.26 (-5.43%)
Price Chart
Overview
About VNDA
vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.
Market Cap
$356.2M
Volume
3.2M
Avg. Volume
2.7M
P/E Ratio
22.2
Dividend Yield
0.00%
Employees
274.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.94
Moderate Correlation
Volatility
High (0.52)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VNDA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$356.2M
Volume3.2M
P/E Ratio22.20
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025